Studies ever conducted, n | |
1–3 | 29 (24.0) |
4–7 | 24 (19.8) |
8–16 | 25 (20.7) |
17–39 | 21 (17.4) |
≥40 | 22 (18.2) |
Used EHR for research | 83 (68.6) |
AHRQ priority health conditions studied (during past 5 years)* | |
Diabetes mellitus | 60 (49.6) |
Obesity | 51 (42.1) |
Pulmonary disease/asthma | 44 (36.4) |
Cardiovascular disease | 42 (34.7) |
Mental health disorders | 34 (28.1) |
Cancer | 32 (26.4) |
Substance abuse | 18 (14.9) |
Development delays | 14 (11.6) |
Infectious disease (including HIV/AIDs, sexually transmitted diseases) | 13 (10.7) |
Dementia | 11 (9.1) |
Arthritis and joint disease | 10 (8.3) |
Pregnancy and childbirth | 10 (8.3) |
Study designs used (during past 5 years)* | |
Observational epidemiology | 66 (54.5) |
Health systems/outcome research | 63 (52.1) |
Best practice research/modeling | 61 (50.4) |
Implementation research | 39 (32.2) |
Clinical trials | 34 (28.1) |
Comparative effectiveness research | 31 (25.6) |
Methodological research | 22 (18.2) |
Nonpractice-based community health intervention | 18 (14.9) |
Pharmaceutical clinical trials | 12 (9.9) |
Data provided as n (%). Ten developing PBRNs that had not completed a research project were excluded from the description of PBRN research.
↵* Multiple responses permitted.
EHR, electronic health record; AHRQ, Agency for Health care Research and Quality.